RESHAPING PURPOSE – USE OF METFORMIN IN ENDOMETRIOSIS AN APPROACH TO RECENT LITERATURE
Accepted
29 March 2026
Available Online
20 July 2019
Abstract
ENDOMETRIOSIS CAN BE CLASSICALLY DEFINED AS THE PRESENCE OF A FUNCTIONAL ENDOMETRIAL LAYER WITH ENDOMETRIAL GLANDS OUTSIDE THE UTERINE CAVITY, INDUCING A CHRONIC, INFLAMMATORY REACTION, LINKED TO CHRONIC PELVIC PAIN AS WELL AS FERTILITY ISSUES. A LARGE AMOUNT OF LITERATURE SURVEYS AS WELL AS CURRENT STUDIES RECKON ENDOMETRIOSIS AS THE RESULT OF A DEFECTIVE IMMUNOSURVEILLANCE CASCADE IN FERTILE WOMEN, SUGGESTING THAT THE CONSTANT PERITONEAL INFLAMMATORY ENVIRONMENT STIMULATES PROGRESS AS WELL AS MAINTENANCE OF THE DISEASE. THEREFORE, NOVEL THERAPEUTICAL APPROACHES ARE NEEDED IN ORDER TO TARGET DIFFERENT PATHOGENIC SPECTRUMS. METFORMIN, A WIDELY USED BIGUANIDE
IMPROVING INSULIN SENSITIVITY IN DIABETES, CAN ALSO PROVIDE BOTH ANTI-INFLAMMATORY PROPERTIES AS WELL AS A MODULATORY EFFECT ON OVARIAN STEROID PRODUCTION, TWO ACTIONS THAT HAVE BEEN SUGGESTED TO OFFER NEW PERSPECTIVES IN ENDOMETRIOSIS THERAPY. MANAGING ENDOMETRIOSIS REQUIRES TARGETING A COMPLEX NETWORK OF LOCALLY PRODUCED CYTOKINES MODULATING THE GROWTH AND INFLAMMATORY BEHAVIOR OF ECTOPIC ENDOMETRIAL IMPLANTS. THEREFORE, WHAT WE DEFINE AS THE MAIN OBJECTIVES OF THIS LITERATURE REVIEW BECOME AS FOLLOWING: TO ASSESS WHETHER METFORMIN MAY BE EFFECTIVE AS A NOVEL APPROACH FOR ENDOMETRIOSIS, DOSE-DEPENDENTLY OR NOT, AS WELL AS TO EVALUATE THE EFFECTS OF THIS AGENT ON INFLAMMATORY RESPONSES, ESTRADIOL PRODUCTION AND NEVERTHELESS ENDOMETRIOTIC STROMAL CELLS PROLIFERATION IN BOTH IN VITRO AND IN VIVO
CONDITIONS.
Keywords
ENDOMETRIOSIS
METFORMIN
IL-8
IL-6
IMMUNOSURVEILLANCE
VEGF
Full Text
The body of this article is intentionally hidden on the public page. Please use the PDF reader or the PDF download for the complete text.
References
[1]
Ferrero, S; Ragni, N; Remorgida, V; Antiangiogenic therapies in endometriosis. British journal of pharmacology. 2006, 149(2): 133-135.
[2]
Brătilă, Elvira; Comandașu, Diana E; Coroleucă, Ciprian; Cârstoiu, Monica M; Berceanu, C; Mehedințu, C; Brătilă, Petre ; Vlădăreanu, S; Diagnosis of endometriotic lesions by sonovaginography with ultrasound gel. Med Ultrason 2016; 18: 469-474.
[3]
Brătilă, Elvira; Ionescu, Oana -Maria; Badiu, Dumitru -Cristinel; Berceanu, Costin; Vlădăreanu, Simona; Pop, Doina Mihaela; Mehedin ţu, Claudia; Umbilical hernia masking primary umbilical endometriosis. Rom J Morphol Embryol, 2016, 57(2): 825-829.
[4]
Mehedintu, Claudia; Antonovici, Marina; Brinduse, Lacramioara; Bratila, Elvira; Stanculescu, Ruxandra; Berceanu, Costin; Bratu, Ovidiu; Pituru, Silviu; Onofriescu, Mircea; Matasariu, Daniela Roxana; The influence of progesterone on immunohystochemical markers in endometriosis, Rev Chim, 2018, 69 (3): 581-584.
[5]
Bodean, Oana -Maria; Voicu, Diana; Munteanu, Octavian; Bratila, Elvira; Bohaltea, Ro xana; Davitoiu, Dragos; Cirstoiu, Monica; Chronic pelvic pain and endometriosis, Res. &Sci. Today, 2015, 10: 206.
[6]
Bremer, Andrew A; Miller, Walter L; Regulation of Steroidogenesis, CellularEndocrinology in Health and Disease, Academic Press, 2014, 207 -227, ISBN 9780124081345, https://doi.org/10.1016/B978 -0-12- 408134-5.00013-5.15.
[7]
Velazquez, EM; Mendoza, S; Hamer, T; Sosa, F; Glueck, CJ; Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy, Metabolism, 1994, 43(5): 647-654.
[8]
Kennedy, S; Bergqvist, A; Chapron, C; et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Human reproduction, 2005, 20(10): 2698-2704.
[9]
Vinatier, D; Orazi, G; Cosson, M; Dufour, P; Theories of endometriosis. European journal of obstetrics, gynecology and reproductive biology, 2001, 96(1): 21-34.
[10]
Bruja, Alexandra; Brinduse, Lacramioara; Bratu, Ovidiu; Diaconu, Camelia; Bratila, Elvira; Methods of transvaginal ultrasound examination in endometriosis. Modern Medicine. 2018, 25 (3): 111-116.
[11]
Nada, Elena -Silvia; Brinduse, Lacramioara; Bratu, Ovidiu; Marcu, Dragos; Bratila, Elvira; Endometriosis-associated infertility, Modern Medicine, 2018, 25 (3): 132.
[12]
Hughes, E; Brown, J; Collins, JJ; Farquhar, C; Fe dorkow, DM; Vandekerckhove, P; Ovulation suppression for endometriosis. The Cochrane database of systematic reviews. 2007, (3): CD000155.
[13]
Shao, Ruijin; et al. Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of wom en with PCOS. Journal of experimental & clinical cancer research, 2014, 33(1): 41. doi:10.1186/1756-9966-33-41.
[14]
Attar, E; Bulun, SE; Aromatase inhibitors: the next generation of therapeutic s for endometriosis? FertilSteril. 2006 May; 85(5): 1307-18.
[15]
Nguyen, L; Chan, SY; Teo, A; Metformin from mother to unborn child - Are there unwarranted effects? EBioMedicine, 2018, 35: 394–404. doi:10.1016/j.ebiom.2018.08.047.
[16]
Li, X; Feng, Y; Lin, JF; Bi llig, H; Shao, R; Endometrial progesterone resistance and PCOS. Journal of biomedical science, 2014, 21(1): 2. doi:10.1186/1423-0127-21-17.
[17]
Takemura, Y; Osuga, Y; Yoshino, O; et al; Metformin suppresses interleukin (IL) -1beta-induced IL-8 production, aromatase activation, and proliferation of endometriotic stromal cells. J Clin Endocrinol Metab. 2007 Aug; 92(8): 213-8.
[18]
Oner, G; Ozcelik, B; Ozgun, MT; Serin, IS; Ozturk, F; Basbug, M; The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model. HumReprod. 2010 Apr; 25(4): 932-7. doi: 10.1093/humrep/deq016.
[19]
Alliegro, Mark; Angiogenesis, Editor(s): S.J. Enna, David B. Bylund, xPharm: The Comprehensive Pharmacology Reference, Elsevier, 2007.
[20]
Boujenah, J; Po ncelet, C; Madelenat, P; The Endometriosis Fertility Index (EFI) is simple to use. GynecolObstetFertil. 2016 May; 44(5): 259-62. doi: 10.1016/j.gyobfe.2016.03.013.
[21]
Foda, Ashraf Ahmed; Abdel Aal, Ibrah im Ahmad; Metformin as a new therapy for endometriosis, its effects on both clinical picture and cytokines profile. Middle East Fertility Society Journal, 2012, 17(4): 262- 267.
[22]
Elnashar, Aboubakr; Emerging treatment of endometriosis. Middle East Fertility Society Journal, 2015, 20(2): 61-69.
[23]
Moravek, MB; Ward, EA; Lebovic, DI; Thiazolidinediones as therapy for endometriosis: a case series. Gynecologic and obstetric investigation, 2009, 68(3): 167–170. doi:10.1159/000230713
[24]
Garavaglia, E; Pagliardini, L; Tandoi, I; Sigismondi, C; Viganò, P; Ferrari, S; Candiani, M; External validation of the endometriosis fertility index (EFI) for predicting spontaneous pregnancy after surgery: further considerations on its validity. Gynecol Obstet Invest. 2015; 79(2): 113-8. doi: 10.1159/000366443.
[25]
Wang, W; Li, R; Fang, T; Huang, L; Ouyang, N; Wang, L; Zhang, Q; Yang, D; Endometriosis fertility index score maybe more accurate for predicting the outcomes of in vitro fertilisation than r-AFS classification in women with endo metriosis. Reprod Biol Endocrinol. 2013 Dec 11; 11:112. doi: 10.1186/1477-7827-11- 112.